HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.2844
-0.0156 (-5.20%)
Mar 31, 2025, 2:23 PM EDT - Market open
HCW Biologics Revenue
In the year 2024, HCW Biologics had annual revenue of $2.57M, down -9.68%. HCW Biologics had revenue of $394.80K in the quarter ending December 31, 2024, a decrease of -70.18%.
Revenue (ttm)
$2.57M
Revenue Growth
-9.68%
P/S Ratio
4.53
Revenue / Employee
$57,040
Employees
45
Market Cap
12.67M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
HCWB News
- 2 days ago - HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - GlobeNewsWire
- 25 days ago - HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements - GlobeNewsWire
- 2 months ago - HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial - GlobeNewsWire
- 2 months ago - HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025 - GlobeNewsWire
- 3 months ago - HCW Biologics Inc. Received NASDAQ Staff Determination Letter - GlobeNewsWire
- 4 months ago - HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - GlobeNewsWire
- 4 months ago - Why Is Penny Stock HCW Biologics Surging On Monday? - Benzinga
- 4 months ago - HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewsWire